{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T08:57:07Z","timestamp":1784883427259,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.jhep.2005.10.017","type":"journal-article","created":{"date-parts":[[2005,11,16]],"date-time":"2005-11-16T07:24:41Z","timestamp":1132125881000},"page":"400-406","source":"Crossref","is-referenced-by-count":170,"title":["Long term outcome and response to therapy of primary biliary cirrhosis\u2014autoimmune hepatitis overlap syndrome"],"prefix":"10.1016","volume":"44","author":[{"given":"Olivier","family":"Chazouill\u00e8res","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Wendum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Serfaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Rosmorduc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Poupon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2005.10.017_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00432159","article-title":"Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis","volume":"373","author":"Kloppel","year":"1977","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.jhep.2005.10.017_bib2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/BF01296147","article-title":"Chronic active hepatitis with histological features of primary biliary cirrhosis","volume":"32","author":"Okuno","year":"1987","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2005.10.017_bib3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1055\/s-2008-1040444","article-title":"A 33-year-old woman with an autoimmune syndrome","volume":"11","author":"Carrougher","year":"1991","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2005.10.017_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hep.1840180103","article-title":"Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis","volume":"18","author":"Ben-Ari","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.10.017_bib5","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/0016-5085(94)90829-X","article-title":"Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis ?","volume":"107","author":"Colombato","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2005.10.017_bib6","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/hep.1840160505","article-title":"M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena?","volume":"16","author":"Davis","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.10.017_bib7","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/BF02064201","article-title":"Primary biliary cirrhosis\u2014autoimmune hepatitis overlap syndrome. Corticoresistance and effective treament by cyclosporine A","volume":"40","author":"Duclos-Vall\u00e9e","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2005.10.017_bib8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis\u2014autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouill\u00e8res","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.10.017_bib9","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.510290409","article-title":"Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals","volume":"29","author":"Lohse","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.10.017_bib10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1053\/jhep.2001.23316","article-title":"Autoimmune overlap syndromes","volume":"33","author":"Woodward","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.10.017_bib11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/gut.49.4.589","article-title":"Autoimmune hepatitis and its variant syndromes","volume":"49","author":"Ben-Ari","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2005.10.017_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1055\/s-2002-35710","article-title":"A 38-year-old African\u2013American woman with an unusually rapid progression of \u2018primary biliary cirrhosis\u2019: a missed opportunity","volume":"22","author":"van Leeuwen","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2005.10.017_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/jhep.2002.30902","article-title":"Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid","volume":"35","author":"Joshi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.10.017_bib14","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2005.10.017_bib15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"Diagnosis and treatment of autoimmune hepatitis","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.10.017_bib16","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep.20646","article-title":"Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial","volume":"41","author":"Rautiainen","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.10.017_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.1840200104","article-title":"Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C","volume":"20","author":"The METAVIR Cooperative Group","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.10.017_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.10.017_bib19","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1089-3261(03)00092-8","article-title":"Autoimmune overlapping syndromes","volume":"7","author":"Poupon","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2005.10.017_bib20","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0168-8278(00)80021-5","article-title":"Diagnosis of primary sclerosing cholangitis\u2014autoimmune hepatitis overlap syndrome: to score or not to score ?","volume":"33","author":"Chazouill\u00e8res","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2005.10.017_bib21","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1053\/jhep.2000.20240","article-title":"The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis","volume":"32","author":"Corpechot","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.10.017_bib22","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1053\/jhep.2002.34853","article-title":"Ursodeoxycholic acid and primary biliary cirrhosis with features of autoimmune hepatitis","volume":"36","author":"Joshi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.10.017_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1440-1746.1998.tb00674.x","article-title":"Efficacy of ursodeoxycholic acid in Japanese patients with type-1 autoimmune hepatitis","volume":"13","author":"Nakamura","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2005.10.017_bib24","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/hep.20188","article-title":"Trials in primary biliary cirrhosis: need for the right drugs at the right time","volume":"39","author":"Poupon","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.10.017_bib25","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.510290444","article-title":"Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression","volume":"29","author":"Degott","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.10.017_bib26","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/gast.2002.31880","article-title":"Primary biliary cirrhosis: incidence and predictive factors of cirrhosis in ursodiol-treated patients","volume":"122","author":"Corpechot","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2005.10.017_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-8278(96)80327-8","article-title":"Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis","volume":"25","author":"Leuschner","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2005.10.017_bib28","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0016-5085(99)70351-3","article-title":"Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial","volume":"117","author":"Leuschner","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2005.10.017_bib29","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/he.2000.5984","article-title":"Management of primary biliary cirrhosis","volume":"31","author":"Heathcote","year":"2000","journal-title":"Hepatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827805006963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827805006963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,20]],"date-time":"2019-01-20T19:54:12Z","timestamp":1548014052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827805006963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0168827805006963"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2005.10.017","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.11518.468998","asserted-by":"object"}]},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}